Home > > > Report Detail

Global Insulin Drug and Delivery Technologies Market Insights, Forecast to 2025

Publisher Name :
Date: 17-Jun-2019
No. of pages: 113
Inquire Before Buying

Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.

The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.

The global Insulin Drug and Delivery Technologies market is valued at 36000 million US$ in 2018 and will reach 67500 million US$ by the end of 2025, growing at a CAGR of 9.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin Drug and Delivery Technologies market based on company, product type, end user and key regions.

This report studies the global market size of Insulin Drug and Delivery Technologies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin Drug and Delivery Technologies in these regions.

This research report categorizes the global Insulin Drug and Delivery Technologies market by top players/brands, region, type and end user. This report also studies the global Insulin Drug and Delivery Technologies market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Sanofi

- Eli Lilly and Company

- Biocon

- Julphar

- Ypsomed

- Becton, Dickinson and Company

Market size by Product

- Insulin Syringes

- Insulin Vials

- Insulin Pens

- Insulin Pumps

Market size by End User

- Diabetes Mellitus Type 1

- Diabetes Mellitus Type 2

- Gestational Diabetes

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Insulin Drug and Delivery Technologies market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Insulin Drug and Delivery Technologies market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Insulin Drug and Delivery Technologies companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Insulin Drug and Delivery Technologies submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Insulin Drug and Delivery Technologies are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin Drug and Delivery Technologies market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Insulin Drug and Delivery Technologies Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Insulin Drug and Delivery Technologies Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Product
1.4.2 Insulin Syringes
1.4.3 Insulin Vials
1.4.4 Insulin Pens
1.4.5 Insulin Pumps
1.5 Market by End User
1.5.1 Global Insulin Drug and Delivery Technologies Market Size Growth Rate by End User
1.5.2 Diabetes Mellitus Type 1
1.5.3 Diabetes Mellitus Type 2
1.5.4 Gestational Diabetes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Insulin Drug and Delivery Technologies Market Size
2.1.1 Global Insulin Drug and Delivery Technologies Revenue 2014-2025
2.1.2 Global Insulin Drug and Delivery Technologies Sales 2014-2025
2.2 Insulin Drug and Delivery Technologies Growth Rate by Regions
2.2.1 Global Insulin Drug and Delivery Technologies Sales by Regions
2.2.2 Global Insulin Drug and Delivery Technologies Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Insulin Drug and Delivery Technologies Sales by Manufacturers
3.1.1 Insulin Drug and Delivery Technologies Sales by Manufacturers
3.1.2 Insulin Drug and Delivery Technologies Sales Market Share by Manufacturers
3.1.3 Global Insulin Drug and Delivery Technologies Market Concentration Ratio (CR5 and HHI)
3.2 Insulin Drug and Delivery Technologies Revenue by Manufacturers
3.2.1 Insulin Drug and Delivery Technologies Revenue by Manufacturers (2014-2019)
3.2.2 Insulin Drug and Delivery Technologies Revenue Share by Manufacturers (2014-2019)
3.3 Insulin Drug and Delivery Technologies Price by Manufacturers
3.4 Insulin Drug and Delivery Technologies Manufacturing Base Distribution, Product Types
3.4.1 Insulin Drug and Delivery Technologies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Drug and Delivery Technologies Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Drug and Delivery Technologies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Insulin Drug and Delivery Technologies Sales by Product
4.2 Global Insulin Drug and Delivery Technologies Revenue by Product
4.3 Insulin Drug and Delivery Technologies Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Insulin Drug and Delivery Technologies Breakdown Data by End User
6 North America
6.1 North America Insulin Drug and Delivery Technologies by Countries
6.1.1 North America Insulin Drug and Delivery Technologies Sales by Countries
6.1.2 North America Insulin Drug and Delivery Technologies Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Insulin Drug and Delivery Technologies by Product
6.3 North America Insulin Drug and Delivery Technologies by End User
7 Europe
7.1 Europe Insulin Drug and Delivery Technologies by Countries
7.1.1 Europe Insulin Drug and Delivery Technologies Sales by Countries
7.1.2 Europe Insulin Drug and Delivery Technologies Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin Drug and Delivery Technologies by Product
7.3 Europe Insulin Drug and Delivery Technologies by End User
8 Asia Pacific
8.1 Asia Pacific Insulin Drug and Delivery Technologies by Countries
8.1.1 Asia Pacific Insulin Drug and Delivery Technologies Sales by Countries
8.1.2 Asia Pacific Insulin Drug and Delivery Technologies Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Insulin Drug and Delivery Technologies by Product
8.3 Asia Pacific Insulin Drug and Delivery Technologies by End User
9 Central & South America
9.1 Central & South America Insulin Drug and Delivery Technologies by Countries
9.1.1 Central & South America Insulin Drug and Delivery Technologies Sales by Countries
9.1.2 Central & South America Insulin Drug and Delivery Technologies Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Insulin Drug and Delivery Technologies by Product
9.3 Central & South America Insulin Drug and Delivery Technologies by End User
10 Middle East and Africa
10.1 Middle East and Africa Insulin Drug and Delivery Technologies by Countries
10.1.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales by Countries
10.1.2 Middle East and Africa Insulin Drug and Delivery Technologies Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Insulin Drug and Delivery Technologies by Product
10.3 Middle East and Africa Insulin Drug and Delivery Technologies by End User
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sanofi Insulin Drug and Delivery Technologies Products Offered
11.1.5 Sanofi Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Company Business Overview
11.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Eli Lilly and Company Insulin Drug and Delivery Technologies Products Offered
11.2.5 Eli Lilly and Company Recent Development
11.3 Biocon
11.3.1 Biocon Company Details
11.3.2 Company Business Overview
11.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Biocon Insulin Drug and Delivery Technologies Products Offered
11.3.5 Biocon Recent Development
11.4 Julphar
11.4.1 Julphar Company Details
11.4.2 Company Business Overview
11.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Julphar Insulin Drug and Delivery Technologies Products Offered
11.4.5 Julphar Recent Development
11.5 Ypsomed
11.5.1 Ypsomed Company Details
11.5.2 Company Business Overview
11.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Ypsomed Insulin Drug and Delivery Technologies Products Offered
11.5.5 Ypsomed Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Company Business Overview
11.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Products Offered
11.6.5 Becton, Dickinson and Company Recent Development
12 Future Forecast
12.1 Insulin Drug and Delivery Technologies Market Forecast by Regions
12.1.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Regions 2019-2025
12.1.2 Global Insulin Drug and Delivery Technologies Revenue Forecast by Regions 2019-2025
12.2 Insulin Drug and Delivery Technologies Market Forecast by Product
12.2.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Product 2019-2025
12.2.2 Global Insulin Drug and Delivery Technologies Revenue Forecast by Product 2019-2025
12.3 Insulin Drug and Delivery Technologies Market Forecast by End User
12.4 North America Insulin Drug and Delivery Technologies Forecast
12.5 Europe Insulin Drug and Delivery Technologies Forecast
12.6 Asia Pacific Insulin Drug and Delivery Technologies Forecast
12.7 Central & South America Insulin Drug and Delivery Technologies Forecast
12.8 Middle East and Africa Insulin Drug and Delivery Technologies Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Drug and Delivery Technologies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Insulin Drug and Delivery Technologies Product Picture
Table Insulin Drug and Delivery Technologies Market Segments
Table Key Manufacturers Insulin Drug and Delivery Technologies Covered
Table Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Insulin Drug and Delivery Technologies Sales Market Share by Product 2014-2025
Figure Insulin Syringes Product Picture
Table Major Manufacturers of Insulin Syringes
Figure Insulin Vials Product Picture
Table Major Manufacturers of Insulin Vials
Figure Insulin Pens Product Picture
Table Major Manufacturers of Insulin Pens
Figure Insulin Pumps Product Picture
Table Major Manufacturers of Insulin Pumps
Table Global Insulin Drug and Delivery Technologies Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Diabetes Mellitus Type 1
Figure Diabetes Mellitus Type 2
Figure Gestational Diabetes
Figure Insulin Drug and Delivery Technologies Report Years Considered
Figure Global Insulin Drug and Delivery Technologies Market Size 2014-2025 (Million US$)
Figure Global Insulin Drug and Delivery Technologies Sales 2014-2025 (K MT)
Table Global Insulin Drug and Delivery Technologies Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Insulin Drug and Delivery Technologies Sales by Regions 2014-2019 (K MT)
Table Global Insulin Drug and Delivery Technologies Sales Market Share by Regions 2014-2019
Figure Global Insulin Drug and Delivery Technologies Sales Market Share by Regions 2014-2019
Figure 2018 Global Insulin Drug and Delivery Technologies Sales Market Share by Regions
Table Global Insulin Drug and Delivery Technologies Revenue by Regions 2014-2019 (Million US$)
Table Global Insulin Drug and Delivery Technologies Revenue Market Share by Regions 2014-2019
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Regions 2014-2019
Figure 2018 Global Insulin Drug and Delivery Technologies Revenue Market Share by Regions
Table Global Insulin Drug and Delivery Technologies Sales by Manufacturers (2014-2019) (K MT)
Table Global Insulin Drug and Delivery Technologies Sales Share by Manufacturers (2014-2019)
Figure Global Insulin Drug and Delivery Technologies Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Insulin Drug and Delivery Technologies Revenue by Manufacturers (2014-2019) (Million USD)
Table Insulin Drug and Delivery Technologies Revenue Share by Manufacturers (2014-2019)
Figure Insulin Drug and Delivery Technologies Value Share by Manufacturers in 2018
Table Key Manufacturers Insulin Drug and Delivery Technologies Price (2014-2019) (USD/MT)
Table Insulin Drug and Delivery Technologies Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Insulin Drug and Delivery Technologies Product Type
Table Date of International Manufacturers Enter into Insulin Drug and Delivery Technologies Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Insulin Drug and Delivery Technologies Sales by Product (2014-2019) (K MT)
Table Global Insulin Drug and Delivery Technologies Sales Share by Product (2014-2019)
Figure Global Insulin Drug and Delivery Technologies Sales Market Share by Product (2014-2019)
Figure Global Insulin Drug and Delivery Technologies Sales Market Share by Product in 2018
Table Global Insulin Drug and Delivery Technologies Revenue by Product (2014-2019) (Million US$)
Table Global Insulin Drug and Delivery Technologies Revenue Share by Product (2014-2019)
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Product (2014-2019)
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Product in 2018
Table Insulin Drug and Delivery Technologies Price by Product 2014-2019 (USD/MT)
Table Global Insulin Drug and Delivery Technologies Sales by End User (2014-2019) (K MT)
Table Global Insulin Drug and Delivery Technologies Sales Share by End User (2014-2019)
Figure Global Sales Insulin Drug and Delivery Technologies Market Share by End User (2014-2019)
Figure Global Sales Insulin Drug and Delivery Technologies Market Share by End User in 2018
Figure North America Insulin Drug and Delivery Technologies Sales Growth Rate 2014-2019 (K MT)
Figure North America Insulin Drug and Delivery Technologies Revenue Growth Rate 2014-2019 (Million US$)
Table North America Insulin Drug and Delivery Technologies Sales by Countries (2014-2019) (K MT)
Table North America Insulin Drug and Delivery Technologies Sales Market Share by Countries (2014-2019)
Figure 2018 North America Insulin Drug and Delivery Technologies Sales Market Share by Countries
Table North America Insulin Drug and Delivery Technologies Revenue by Countries (2014-2019) (Million US$)
Table North America Insulin Drug and Delivery Technologies Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Insulin Drug and Delivery Technologies Revenue Market Share by Countries
Figure United States Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure United States Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Canada Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Table North America Insulin Drug and Delivery Technologies Sales by Product (2014-2019) (K MT)
Table North America Insulin Drug and Delivery Technologies Sales Market Share by Product (2014-2019)
Figure 2018 North America Insulin Drug and Delivery Technologies Market Share by Product
Table North America Insulin Drug and Delivery Technologies Sales by End User (2014-2019) (K MT)
Table North America Insulin Drug and Delivery Technologies Sales Market Share by End User (2014-2019)
Figure 2018 North America Insulin Drug and Delivery Technologies Market Share by End User
Figure Europe Insulin Drug and Delivery Technologies Sales Growth Rate 2014-2019 (K MT)
Figure Europe Insulin Drug and Delivery Technologies Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Insulin Drug and Delivery Technologies Sales by Countries (2014-2019) (K MT)
Table Europe Insulin Drug and Delivery Technologies Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Insulin Drug and Delivery Technologies Sales Market Share by Countries
Table Europe Insulin Drug and Delivery Technologies Revenue by Countries (2014-2019) (Million US$)
Table Europe Insulin Drug and Delivery Technologies Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Insulin Drug and Delivery Technologies Revenue Market Share by Countries
Figure Germany Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Germany Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure France Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure France Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure UK Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Italy Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Russia Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Insulin Drug and Delivery Technologies Sales by Product (2014-2019) (K MT)
Table Europe Insulin Drug and Delivery Technologies Sales Market Share by Product (2014-2019)
Figure 2018 Europe Insulin Drug and Delivery Technologies Market Share by Product
Table Europe Insulin Drug and Delivery Technologies Sales by End User (2014-2019) (K MT)
Table Europe Insulin Drug and Delivery Technologies Sales Market Share by End User (2014-2019)
Figure 2018 Europe Insulin Drug and Delivery Technologies Market Share by End User
Figure Asia Pacific Insulin Drug and Delivery Technologies Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Insulin Drug and Delivery Technologies Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Insulin Drug and Delivery Technologies Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Insulin Drug and Delivery Technologies Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Insulin Drug and Delivery Technologies Sales Market Share by Countries
Table Asia Pacific Insulin Drug and Delivery Technologies Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Insulin Drug and Delivery Technologies Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Insulin Drug and Delivery Technologies Revenue Market Share by Countries
Figure China Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure China Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Japan Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Korea Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure India Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure India Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Australia Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Insulin Drug and Delivery Technologies Sales by Product (2014-2019) (K MT)
Table Asia Pacific Insulin Drug and Delivery Technologies Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Insulin Drug and Delivery Technologies Market Share by Product
Table Asia Pacific Insulin Drug and Delivery Technologies Sales by End User (2014-2019) (K MT)
Table Asia Pacific Insulin Drug and Delivery Technologies Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Insulin Drug and Delivery Technologies Market Share by End User
Figure Central & South America Insulin Drug and Delivery Technologies Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Insulin Drug and Delivery Technologies Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Insulin Drug and Delivery Technologies Sales by Countries (2014-2019) (K MT)
Table Central & South America Insulin Drug and Delivery Technologies Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Insulin Drug and Delivery Technologies Sales Market Share by Countries
Table Central & South America Insulin Drug and Delivery Technologies Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Insulin Drug and Delivery Technologies Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Insulin Drug and Delivery Technologies Revenue Market Share by Countries
Figure Brazil Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Insulin Drug and Delivery Technologies Sales by Product (2014-2019) (K MT)
Table Central & South America Insulin Drug and Delivery Technologies Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Insulin Drug and Delivery Technologies Market Share by Product
Table Central & South America Insulin Drug and Delivery Technologies Sales by End User (2014-2019) (K MT)
Table Central & South America Insulin Drug and Delivery Technologies Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Insulin Drug and Delivery Technologies Market Share by End User
Figure Middle East and Africa Insulin Drug and Delivery Technologies Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Insulin Drug and Delivery Technologies Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Insulin Drug and Delivery Technologies Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by Countries
Table Middle East and Africa Insulin Drug and Delivery Technologies Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Insulin Drug and Delivery Technologies Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Insulin Drug and Delivery Technologies Revenue Market Share by Countries
Figure GCC Countries Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Insulin Drug and Delivery Technologies Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Insulin Drug and Delivery Technologies Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Insulin Drug and Delivery Technologies Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Insulin Drug and Delivery Technologies Market Share by Product
Table Middle East and Africa Insulin Drug and Delivery Technologies Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Insulin Drug and Delivery Technologies Market Share by End User
Table Sanofi Company Details
Table Sanofi Insulin Drug and Delivery Technologies Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Insulin Drug and Delivery Technologies Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table Biocon Company Details
Table Biocon Insulin Drug and Delivery Technologies Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Biocon Recent Development
Table Julphar Company Details
Table Julphar Insulin Drug and Delivery Technologies Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Julphar Recent Development
Table Ypsomed Company Details
Table Ypsomed Insulin Drug and Delivery Technologies Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Ypsomed Recent Development
Table Becton, Dickinson and Company Company Details
Table Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Becton, Dickinson and Company Recent Development
Table Global Insulin Drug and Delivery Technologies Sales Forecast by Regions 2019-2025 (K MT)
Table Global Insulin Drug and Delivery Technologies Sales Market Share Forecast by Regions 2019-2025
Table Global Insulin Drug and Delivery Technologies Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Insulin Drug and Delivery Technologies Revenue Market Share Forecast by Regions 2019-2025
Table Global Insulin Drug and Delivery Technologies Sales Forecast by Product 2019-2025 (K MT)
Table Global Insulin Drug and Delivery Technologies Sales Market Share Forecast by Product 2019-2025
Table Global Insulin Drug and Delivery Technologies Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Insulin Drug and Delivery Technologies Revenue Market Share Forecast by Product 2019-2025
Table Global Insulin Drug and Delivery Technologies Sales Forecast by End User 2019-2025 (K MT)
Table Global Insulin Drug and Delivery Technologies Sales Market Share Forecast by End User 2019-2025
Figure North America Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Insulin Drug and Delivery Technologies Value Chain
Table Insulin Drug and Delivery Technologies Customers List
Table Insulin Drug and Delivery Technologies Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs